Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SEALSQ Announces $125.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Powered Land: Jet.AI and Consensus Core Complete Milestone Three of Canadian Hyperscale Data Center Projects
-
Vivakor Receives Nasdaq Panel Approval for Path to Continued Listing, Upon Compliance by April 30, 2026
-
Record Gold Prices Reshape Economics of New Mine Development
-
VisionWave Aligns With Largest Creditor of C.M., Advancing Planned Acquisition of Israeli Defense Manufacturing Platform
-
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
-
Critical Metals Corp Appoints Chang Oh Turkmani to Its Advisory Board
-
Endeavor Files Preliminary Consent Materials to Remove Entire Board of Directors at Mawson Infrastructure Group
-
Off The Hook to Participate in the 38th Annual ROTH Conference
-
Webinar to Explore Why the Auto Industry Isn’t Saying Goodbye to Engines
-
Founder Group Limited Secures US$5 Million EPC Contract for a 5.5MW Solar Plant under Malaysia’s LSS5 PETRA Programme
-
SUNation Energy Schedules 2025 Fourth Quarterand Full Year Financial Results and Conference Call
-
Draganfly Demonstrates Advanced Drone Capabilities for Canadian Armed Forces Following MINERVA Working Group Participation
-
Atlantic International to Attend 38th Annual ROTH Conference
-
BTCS Strategically Revises 2026 Executive Performance Incentive Program to Focus on Profitability
-
Standard Lithium Bolsters National Security Focus by Adding Expert Critical Minerals and Defense Advisors
-
Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign Prostatic Hyperplasia
-
IP Strategy to Present at the 38th Annual ROTH Conference
-
Purchaser Business Group on Health’s ‘2026 Health Policy Summit’ Convenes Employer Purchasers and Policy Leaders to Advance Affordability, Transparency and Accountability
-
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
-
A Race Against Blindness Announces Spring 2026 Luxury Vehicle Fundraiser in Partnership with Foundation Fighting Blindness to Advance Pediatric Inherited Retinal Disease Research
-
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the
-
Osisko Development Announces Inclusion in the GDXJ
-
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the
-
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
-
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
-
Millions Locked Out of Banking May Soon Find an Alternative at the Checkout Line. Alpha Cash Plans to Be That Alternative
-
Offer Update
-
Maris-Tech Receives Order from Governmental Defense Entity for Situational Awareness and Drone Video Payload Applications
-
FinHarbor Introduces Neobank Platform Designed to Go Live in Under 30 Days
-
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
-
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
-
Asure Software to Attend 38th Annual Roth Conference
-
Halleck Creek Ore Selected for Feedstock for the DoE METALLIC Research Consortium
-
VEON Files its 2025 Annual Report on Form 20-F
-
FullPAC CEO to Outline Future of Election Tech at 2026 Pollie Awards & Conference
-
Athabasca Oil Announces Renewal of Normal Course Issuer Bid
-
Asante Provides Operations Update
-
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
-
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
-
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth
-
Amazon Web Services (AWS) Recognizes Fusemachines with AI Services Competency Partner (Generative AI) Status, Joining an Elite Group of Global AI Leaders
-
FullPAC CEO to Outline Future of Election Tech at 2026 Pollie Awards & Conference
-
Aspen Group Reports Fourth Consecutive Quarter of Net Income for Third Quarter Fiscal 2026
-
Enphase Energy and Ensol Partner to Expand Home Battery Adoption in France
-
Lightbridge Commends U.S. Department of Energy’s Launch of UPRISE Initiative to Accelerate U.S. Nuclear Energy Expansion
-
Beyond Oil Becomes Approved Vendor of Premium Casual Dining Chain in the United States
-
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
-
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
-
Byrna Technologies Appoints Robert Holmes as Vice President of New Product Development and R&D
